Documentation Centre

 

 

  of 411 Next page

Go to page: of

Screenshot Date Categories Title Author Format
As a clinician and a scientist, could you comment on the respective contributions of clinical (individual) and population-based approaches to prevent/manage type 2 diabetes? April 09, 2019 As a clinician and a scientist, could you comment on the respective contributions of clinical (individual) and population-based approaches to prevent/manage type 2 diabetes? Nicholas J. Wareham, MB, PhD, Professor and Director, MRC Epidemiology Unit, University of Cambridge, Cambridge, UK Expert Opinions
Video 1:30 min.
(8 MB)
How would you describe lifestyle resistant hypertensive? March 27, 2019 How would you describe lifestyle resistant hypertensive? Saverio Stranges, MD, PhD, FAHA, Professor and Chair, Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada Expert Opinions
Video 1:46 min.
(10 MB)
Among all great studies and papers that you have published, which is your favorite and why? March 13, 2019 Among all great studies and papers that you have published, which is your favorite and why? Marja-Riitta Taskinen, MD, PhD, Emerita Professor of Medicine, Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki University Hospital, Helsinki, Finland Expert Opinions
Video 1:11 min.
(6 MB)
In which context do you think measuring waist circumference is useful in clinical practice? February 27, 2019 In which context do you think measuring waist circumference is useful in clinical practice? Jaap Seidell, PhD, Department of Health Sciences, Amsterdam Public Health Research Institute, and the EMGO Institute for Health and Care Research, VU University Amsterdam, Amsterdam, The Netherlands Expert Opinions
Video 0:43 min.
(3 MB)
What do you think is the most important to reduce the cardiovascular disease risk of visceral obesity: to increase physical activity or to improve cardiorespiratory fitness? February 12, 2019 What do you think is the most important to reduce the cardiovascular disease risk of visceral obesity: to increase physical activity or to improve cardiorespiratory fitness? Robert Ross, PhD, Professor, School of Kinesiology and Health Studies, Department of Medicine, Division of Endocrinology and Metabolism, Queen's University, Kingston, ON, Canada Expert Opinions
Video 2:35 min.
(14 MB)
What are the low-hanging fruits to combat the epidemic of type 2 diabetes? December 20, 2018 What are the low-hanging fruits to combat the epidemic of type 2 diabetes? Gillian Booth, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Toronto; Adjunct Scientist, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Expert Opinions
Video 0:57 min.
(5 MB)
If we are very sedentary during our work time, can we nevertheless reduce our cardiovascular disease risk by being active during our leisure time? How much leisure-time physical activity do we need? December 20, 2018 If we are very sedentary during our work time, can we nevertheless reduce our cardiovascular disease risk by being active during our leisure time? How much leisure-time physical activity do we need? I-Min Lee, MD, MPH, ScD, Professor, Brigham and Women's Hospital, Harvard Medical School, T.H. Chan School of Public Health, Boston, MA, USA Expert Opinions
Video 1:30 min.
(8 MB)
To what extent do you think that the finding of the remarkable PREDIMED study can be exported to other parts of the world? December 20, 2018 To what extent do you think that the finding of the remarkable PREDIMED study can be exported to other parts of the world? Emilio Ros, MD, PhD, Director, Lipid Clinic; Senior Consultant, Endocrinology and Nutrition Service, Hospital Clínic, Barcelona, Spain Expert Opinions
Video 1:27 min.
(8 MB)
Why is cardiorespiratory fitness still not assessed in clinical practice? December 19, 2018 Why is cardiorespiratory fitness still not assessed in clinical practice? Steven N. Blair, P.E.D., FACSM, Professor (retired), Departments of Exercise Science and Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA Expert Opinions
Video 1:15 min.
(7 MB)
As a clinician and a scientist, could you comment on the successes and surprises of atherosclerosis research? December 05, 2018 As a clinician and a scientist, could you comment on the successes and surprises of atherosclerosis research? Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA, USA Expert Opinions
Video 3:55 min.
(22 MB)

  of 411 Next page

Go to page: of